 | articles |
Browse Trials by date - 2010-2019
- 2000-2009
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
| | Latest articles [more info] Articles in Volume 2 | Editorial
 Are there fundamental deficiencies in the megatrial methodology? Desmond Julian, Curt Furberg Current Controlled Trials in Cardiovascular Medicine 2001, 2:1 (9 February 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 Fundamental deficiencies in the megatrial methodology Bruce G Charlton Current Controlled Trials in Cardiovascular Medicine 2001, 2:2-7 (30 January 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] Commentary
 Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low" Sergio Fazio, MacRae F Linton Current Controlled Trials in Cardiovascular Medicine 2001, 2:8-11 (30 January 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl" W Virgil Brown MD Current Controlled Trials in Cardiovascular Medicine 2001, 2:12-15 (9 February 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 The Proliferation REduction with Vascular ENergy Trial (PREVENT) Albert E Raizner, Grzegorz L Kaluza Current Controlled Trials in Cardiovascular Medicine 2001, 2:16-19 (1 February 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
  The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial Eric J Eichhorn, Michael R Bristow Current Controlled Trials in Cardiovascular Medicine 2001, 2:20-23 (2 February 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Review
 The current status of primary prevention in coronary heart disease Cornel Pater Current Controlled Trials in Cardiovascular Medicine 2001, 2:24-37 (30 January 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] Review
 Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials Steven Warach Current Controlled Trials in Cardiovascular Medicine 2001, 2:38-44 (30 January 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Review
 New immunosuppressive drugs in heart transplantation Maria Rosa Costanzo Current Controlled Trials in Cardiovascular Medicine 2001, 2:45-53 (8 February 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Research
 Experience collecting interim data on mortality: an example from the RALES study Janet Wittes, Jolie Palensky, Debra Asner, Desmond Julian, Jean-Pierre Boissel, Curt D Furberg, Henri Kulbertus, Stuart Pocock, Barbara Roniker Current Controlled Trials in Cardiovascular Medicine 2001, 2:59-62 (7 February 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 Debate: does it matter how you lower blood pressure? Gordon T McInnes Current Controlled Trials in Cardiovascular Medicine 2001, 2:63-66 (1 March 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 Ablation of atrial fibrillation: a procedure come of age? J Marcus Wharton Current Controlled Trials in Cardiovascular Medicine 2001, 2:67-70 (5 April 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products William M Vollmer, Frank M Sacks, Laura P Svetkey Current Controlled Trials in Cardiovascular Medicine 2001, 2:71-74 (11 April 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Review
 Implications of troponin testing in clinical medicine Britta U Goldmann, Robert H Christenson, Christian W Hamm, Thomas Meinertz, E Magnus Ohman Current Controlled Trials in Cardiovascular Medicine 2001, 2:75-84 (11 April 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Meeting report
 Selected highlights from the 50th Annual Scientific Session of the American College of Cardiology, Orlando, USA, 18-21 March 2001 Joanna Lyford Current Controlled Trials in Cardiovascular Medicine 2001, 2:85-89 (11 April 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Research
 No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 months Ronnie Willenheimer, Steen Juul-Möller, Lennart Forslund, Leif Erhardt Current Controlled Trials in Cardiovascular Medicine 2001, 2:99-105 (4 April 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions Curt D Furberg Current Controlled Trials in Cardiovascular Medicine 2001, 2:107-108 (31 May 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] Commentary
 Bridging case-control studies and randomized trials Frits R Rosendaal Current Controlled Trials in Cardiovascular Medicine 2001, 2:109-110 (31 May 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins? David Waters, Gregory G Schwartz, Anders G Olsson Current Controlled Trials in Cardiovascular Medicine 2001, 2:111-114 (31 May 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary
 Data quality assurance and quality control measures in large multicenter stroke trials: the African-American Antiplatelet Stroke Prevention Study experience DeJuran Richardson, Shande Chen Current Controlled Trials in Cardiovascular Medicine 2001, 2:115-117 (25 May 2001) [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
|
|  
|